Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop ONCOIMMUNOLOGY Houot, R., Gaulard, P., Schreiber, R., Mellman, I., Lambotte, O., Coulie, P. G., Fest, T., Korman, A., Levy, R., Shipp, M., Tarte, K., Kohrt, H., Marabelle, A., Ansell, S., Watier, H., van Elsas, A., Balakumaran, A., Vargas, F. A., Quezada, S. A., Salles, G., Olive, D. 2016; 5 (7)


In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.

View details for DOI 10.1080/2162402X.2016.1186323

View details for Web of Science ID 000385486700031

View details for PubMedID 27622041

View details for PubMedCentralID PMC5006908